ArticleCellular oncology (Dordrecht, Netherlands)2016

Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker.

Renato José Silva-Oliveira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.